Maolac, a biotech company, has recently launched two new products called Maolactin for Gut Support and Maolactin for Anti-Inflammatory Activity. These innovative products combine breast milk and artificial intelligence to harness the beneficial properties of breast milk while leveraging computational biology and generative AI technology.
Breast milk has long been celebrated for its immune-boosting properties, aiding in brain and bone development, and exerting anti-inflammatory effects. Recognizing the remarkable benefits of breast milk, Maolac developed the Maoreka algorithm, which aims to reimagine breast milk’s composition as the gold standard using AI technology.
The Maoreka algorithm allows Maolac to identify specific protein combinations for various indications through extensive research and keyword searches. With this technology, the company can predict and produce new protein mixtures that are active and precise for achieving desired effects.
Maolac’s new products, Maolactin for Gut Support and Maolactin for Anti-Inflammatory Activity, use proteins derived from bovine colostrum, which has a high similarity (over 95%) to human breast milk. These protein mixes are heat- and pH-proof, seamlessly integrating into different daily routines and consumption formats.
The CEO of Maolac ensures that these protein mixes do not affect the sensory properties of the final product. They can be easily mixed with water or incorporated into various products like functional beverages, sports bars, and smoothies. This flexibility allows consumers to choose the most convenient way to include these products in their daily routines.
While Maolac keeps the exact composition of their new products proprietary, they reveal that the proteins used bear a high similarity to human breast milk. These proteins, honed by evolution, provide proper nutrition and targeted benefits for gut health and anti-inflammatory support, combining Mother Nature’s wisdom with scientific advancements.
Maolactin for Gut Support and Maolactin for Anti-Inflammatory Activity are the first products launched by Maolac, reflecting their ongoing commitment to innovation in developing products that promote wellness and address specific health goals. Initially, the company targets the US and Europe, having achieved Self Affirmed GRAS in the US, with plans for global expansion, aiming to provide high-quality, affordable supplements worldwide.
Maolac’s Maoreka platform enables the creation of uniquely potent functional ingredients that can be integrated into any food or supplement. The company continues to invest in upgrading its AI capabilities to provide more targeted protein-based compositions from both animal and non-animal sources, moving beyond colostrum alone. By exploring different raw materials, such as fungi, algae, and other plants, Maolac is committed to creating premium ingredients that are sustainable and bring good to the world.
The global immunity-boosting food market is estimated to reach $46.9 million by 2030, according to Allied Market Research. With Maolac’s technology, the company anticipates a seismic shift in the sector, meeting the rising demand for innovative and sustainable food and drink products that promote immune health and overall wellness.
